ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,442.00
2.14%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,232.44
0.55%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) 뉴스

HRTX Heron Therapeautics Inc

2.60
0.05 (1.96%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Heron Therapeautics Inc HRTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.05 1.96% 2.60 08:23:05
개장가 저가 고가 종가 전일 종가
2.67 2.57 2.74 2.61 2.55
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202421:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
12/04/202405:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
29/03/202405:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
14/03/202405:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
13/03/202405:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12/03/202420:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
28/02/202422:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
15/02/202406:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202423:25APSPremarket Heats Up For Biotech Before Opening Bell
24/01/202422:01EDGAR2Form 8-K - Current report
24/01/202410:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
20/01/202411:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202406:07EDGAR2Form 8-K - Current report
08/01/202407:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
23/12/202306:30EDGAR2Form 8-K - Current report
22/12/202307:25EDGAR2Form 8-K - Current report
07/12/202306:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/11/202302:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202302:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202302:25APSBiotech Shares Up Sharply Following Quarterly Results
15/11/202306:10EDGAR2Form 8-K - Current report
15/11/202306:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
08/11/202306:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
18/10/202308:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/08/202305:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:08EDGAR2Form S-3 - Registration statement under Securities Act of..
15/08/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:11EDGAR2Form 8-K - Current report
15/08/202305:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
08/08/202305:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
02/08/202302:56EDGAR2Form D - Notice of Exempt Offering of Securities
26/07/202305:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/07/202305:13EDGAR2Form SC 13D/A - General statement of acquisition of..
24/07/202322:12EDGAR2Form 8-K - Current report
24/07/202322:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
24/07/202322:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
20/07/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202306:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유